The FDA has withdrawn its accelerated approval of Krazati (adagrasib) combined with Erbitux (cetuximab) for adults with KRAS G12C-mutated colorectal cancer that is locally advanced or has spread to ...

Arlo-cel uses autologous T-cell collection, ex vivo CAR engineering, lymphodepletion, and single infusion, necessitating infrastructure for manufacturing logistics and post-infusion monitoring. Safety ...

Upcoming changes to how Medicare handles ostomy supplies could affect cancer survivors who rely on specific products after treatment, according to Dr. Diego Schaps.

For patients receiving chemotherapy for aggressive lymphoma, we may see lower blood counts, which can increase the risk of infection. Some patients may need blood or platelet transfusions. Hair loss ...

Dr. Diego Schaps discussed how upcoming Medicare competitive bidding changes could affect access to ostomy supplies and why having the right pouching system matters for patients.

Alcohol-attributable cancer deaths more than doubled from 1990 to 2023, and the national age-standardized mortality rate rose ...

Actor and advocate Mariska Hargitay has partnered with Bristol Myers Squibb on "Investigating Myeloma," a disease awareness ...

Therapy planning shifted from intended autologous transplant to CAR-T; detailed counseling helped align expectations and ...

Cancer survivor Brynn Forlizzi and caregiver Teddy Aaron created SootheNote, an app designed to help cancer patients and ...

Gonadotoxic therapy can abruptly threaten fertility in AYA breast cancer, making preservation counseling time-sensitive and ...

The FDA approved six cancer drugs in August 2026, including a landmark pancreatic cancer pill. Here's what each approval ...

FDA approves BESREMi for adults with essential thrombocythemia, offering a new treatment option for people living with this ...